Fierce JPM Week - Virtual Agenda has ended
Back To Schedule
Thursday, January 20 • 1:00pm - 2:00pm
Digital first launches - The new post-COVID landscape

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

As a result of the pandemic, many pharma and biotech companies could not launch products in the same manner as they had done previously with face-to-face interactions with HCPS.  Companies needed to adapt and launch their products completely digitally which created unique challenges but also new opportunities for the future.  We will look at what worked, what didn’t and discuss strategies for these types of launches going forward.

avatar for Stephanie Butler

Stephanie Butler

Senior Conference Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences.  Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →

avatar for Gina Chapman

Gina Chapman

Senior Vice President, OMNI Business Unit Head, Genentech
As Senior Vice President, OMNI Business Unit Head at Genentech, Gina leads a team of ~260 people, including Marketing teams, who report directly into therapeutic area Squad Leads. Access, Medical and Field partners are a part of the Business Unit network. The OMNI Business Unit is... Read More →
avatar for Robert La Caze

Robert La Caze

Member of the Executive Committee of Bayer's Pharmaceutical Division and Head of the Oncology SBU,, Bayer Pharmaceuticals
Robert LaCaze is an accomplished and recognized oncology leader with focus on driving innovation and value for patients. Robert’s success is driven by his passion for Oncology and 30 years of bio-pharmaceutical experience mainly in specialty areas like Oncology. Currently as the... Read More →
avatar for David Libby

David Libby

SVP, Region Head North America, Ultragenyx
David is currently Senior Vice President, North America Region for Ultragenyx a leading biotechnology company focused on finding breakthrough treatments for rare diseases leveraging multiple modalities including gene therapies, mRNA, and recombinant DNA biologic treatments. David... Read More →
avatar for Lars Merk

Lars Merk

Sr. Director Global Commercial Digital & Innovation, AstraZeneca
Lars Merk is the Global Director of Omnichannel Strategy for Astra Zeneca. He is known for driving innovation and business results by maintaining both marketing discipline and customer focus in his roles over the years. Lars has consistently been recognized by the industry as an innovative... Read More →

Thursday January 20, 2022 1:00pm - 2:00pm EST